RedHill Biopharma (RDHL) Net Margin (QoQ) (2012 - 2023)
RedHill Biopharma (RDHL) Net Margin (QoQ) (2012 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - |
| 10 | RedHill Biopharma | 2.05 Bn | 2.05 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 350,071.00 |
| Mar 31, 2023 | 32,318.00 |
| Dec 31, 2022 | -42,081.00 |
| Sep 30, 2022 | -12,241.00 |
| Jun 30, 2022 | -9,715.00 |
| Mar 31, 2022 | 74,143.00 |
| Dec 31, 2021 | -70,634.00 |
| Sep 30, 2021 | 6,205.00 |
| Jun 30, 2021 | -6,533.00 |
| Mar 31, 2021 | 1,623.00 |
| Dec 31, 2020 | 0.00 |
| Sep 30, 2020 | 626.00 |
| Jun 30, 2020 | -151,464.00 |
| Mar 31, 2020 | 81,302.00 |
| Dec 31, 2019 | 1,499.00 |
| Sep 30, 2019 | -17,423.00 |
| Jun 30, 2019 | 41,114.00 |
| Mar 31, 2019 | -42,001.00 |
| Dec 31, 2018 | 48,697.00 |
| Sep 30, 2018 | 42,561.00 |